Search clinical trials for: Dotarem (gadoterate meglumine)

Total 190 results

Guerbet

Completed

Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions (SENTIO)

Central Nervous System Diseases | Diagnostic Self Evaluation

United States, Korea, Republic of, Argentina, Spain, France, Austria, Germany, Brazil, Chile, Italy, United Kingdom
Donna Roberts
National Institute of Standards and Technology

Recruiting

Gadolinium Retention in Human Bone Tissue in Pediatric Patients

Magnetic Resonance Imaging | Gadolinium Retention | Gadolinium | MultiHance | Dotarem

United States
Guerbet
Bayer AG (Sponsor); Bracco (Sponsor); GEHC (Sponsor)

Recruiting

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years (ODYSSEY)

Cognitive Function | Motor Function | Contrast Media

United States, Korea, Republic of, Italy, Brazil, Canada, Russian Federation, France, Germany
University of Michigan

Completed

Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration

Liver Tumor

United States
Duke University
University of California, San Diego; University of Wisconsin, Madison

Completed

Eovist vs. Dotarem Healthy Volunteer MRI

Transient Severe Arterial Phase Motion

United States
University of Colorado, Denver
National Cancer Institute (NCI); Bracco Diagnostics, Inc

Recruiting

Comparison of Contrast Agents in Liver MR for the Detection of Hepatic Metastases

Colorectal Cancer | Liver Metastases | Oligometastatic Disease

United States
University of Chicago
Guerbet

Completed

Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)

Breast Cancer | Breast Neoplasms | Breast Diseases | Breast Fibroadenoma

United States
Guerbet

Completed

DOTAREM Pharmacokinetics and Safety Study in Pediatric Subjects Aged < 2 Years

Magnetic Resonance Imaging

France, Austria, Hungary, Poland
Phoenix Children's Hospital
Guerbet

Completed

Intra-individual Open-label, Single Center Study to Compare Unenhanced MRI With Dotarem Enhanced MRI

Brain Diseases

United States
Massachusetts General Hospital
Boehringer Ingelheim

Recruiting

Collagen-targeted PET Imaging for Early Interstitial Lung Disease

Interstitial Lung Disease

United States
Guerbet

Terminated

DCE-MRI Using Dotarem® in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC (DCE-MRI)

Hepatocellular Carcinoma

Korea, Republic of
University of Massachusetts, Worcester
Guerbet

Recruiting

Dotarem vs Gadobutrol Contrast for Breast MRI

Breast Diseases

United States
Guerbet

Completed

Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

Cerebral Arterial Diseases

United States
Guerbet

Completed

Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis (ACCREDIT)

Type 2 Diabetes Mellitus | Coronary Atherosclerosis

Korea, Republic of
Guerbet

Terminated

Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time-Of-Flight (TOF)

Renal Disease

United States
Guerbet

Recruiting

Performance of Elucirem® in DSC-MRI Perfusion of Brain Gliomas (GDX-44-016)

Brain Tumor, Recurrent | Brain Tumor, Primary

Italy, Hungary, Poland
Guerbet

Completed

Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

Cerebral Arterial Diseases

United States
Bracco Diagnostics, Inc

Completed

Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral Arteries (VALUE)

Carotid, Aortic, Renal or Peripheral Artery Disease

China
Bracco Diagnostics, Inc

Completed

Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS Patients

Central Nervous System Diseases | Central Nervous System Neoplasms

United States
Bracco Diagnostics, Inc

Completed

Retrospective Study of MRI in Pediatric Patients

Central Nervous System Neoplasms | Central Nervous System Disease
Guerbet

Completed

Post-marketing Surveillance Study for Evaluation of Dotarem Safety

Contrast-enhanced MRI With Dotarem
Guerbet

Terminated

Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

Renal Artery Stenosis

United States
Guerbet

Completed

Renal Safety Evaluation After Dotarem®-Enhanced MRI (RESCUE)

Renal Insufficiency

France, Belgium, Spain, Italy
Bracco Diagnostics, Inc

Terminated

Safety and Efficacy of MultiHance in Pediatric Patients

Central Nervous System Diseases

United States
Guerbet

Completed

Post Marketing Surveillance Study for Evaluation of Efficacy and Safety of Dotarem in Magnetic Resonance Mammography

MR Mammography With Dotarem
Guerbet

Completed

Safety and Dialysability of Dotarem® in Dialysed Patients

End-stage Renal Failure

Belgium
Bracco Diagnostics, Inc

Completed

Multihance at 3 Tesla (3T) in Brain Tumors

Brain Tumor

United States
University of Southern California
National Cancer Institute (NCI)

Withdrawn

QSM and Regional DCE MRI Permeability Using GOCART Technique

Intracranial Neoplasm

United States
University of California, San Diego
Bracco Imaging S.p.A.

Not yet recruiting

Comparative Effectiveness of Gadopiclenol for Evaluation of Adult Congenital Heart Anatomy and Hemodynamics

Congenital Heart Disease

United States
Loyola University
Guerbet

Unknown

Evaluation of Gadoterate in Patients With Decreased Kidney Function

Renal Dysfunction

United States
Guerbet

Completed

P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)

Blood Brain Barrier Defect | CNS Lesion

Korea, Republic of, United States, Czechia, Italy, Belgium, Poland, Hungary, Mexico
Bayer

Completed

Comparison of Gadovist 75% Standard Dose to Dotarem at Full Standard Dose (LEADER 75)

Magnetic Resonance Imaging

United States, Korea, Republic of, France, Germany, Italy, Switzerland, United Kingdom
University of Campinas, Brazil
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Doxorubicin-associated Cardiac Remodeling Followed by CMR in Breast Cancer Patients

Breast Cancer Female | Doxorubicin Induced Cardiomyopathy

Brazil
Sidney Kimmel Comprehensive Cancer Center at Johns...
Bracco Diagnostics, Inc

Completed

Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI. (TACE)

Hepatocellular Carcinoma

United States
Guerbet

Completed

Efficacy Evaluation of Dotarem Compared to Gadovist in the Diagnosis of Peripheral Arterial Disease (DALIA)

Peripheral Arterial Disease

Austria
Vanderbilt University Medical Center
Children's Hospital of Philadelphia; Guerbet

Completed

Gadolinium-Based-Contrast-Agents (GBCA) Enhancement During MR Urography

Magnetic Resonance Imaging Contrast Agents

United States
Northwestern University

Completed

Efficacy of Gadoterate Meglumine in Diagnosis of Vascular Diseases Using MRA MRA

Vascular Diseases

United States
Jiangsu Kanion Pharmaceutical Co., Ltd
Beijing Bionovo Medicine Development Co., Ltd.

Completed

A Pilot Study for Ginkgolides Meglumine Injection Skin Testing.

Allergy

China
Bracco Diagnostics, Inc

Completed

Crossover Comparison of MultiHance and Dotarem (BENEFIT)

Brain Disease

United States
Dongzhimen Hospital, Beijing

Completed

Efficacy of Diterpene Ginkgolides Meglumine Injection in Elderly Patients With Ischemic Stroke

Stroke | Nervous System Diseases | Ischemic Stroke | Brain Ischemia | Cerebral Infarction | Brain Infarction

China
Bayer

Recruiting

A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems) (Quanti OBR)

Contrast Enhancement in Magnetic Resonance Imaging | Non-central Nervous System Pathology

United States, Sweden, Japan, Czechia, China, Hungary, Poland, Italy, United Kingdom, Turkey, Korea, Republic of, Germany, Taiwan, France, Argentina, Bulgaria, Canada
University of Southern California
National Cancer Institute (NCI)

Terminated

Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases

Multiple Sclerosis | Metastatic Malignant Neoplasm in the Brain | Adult Anaplastic Astrocytoma | Adult Anaplastic Ependymoma | Adult Anaplastic Oligodendroglioma | Adult Diffuse Astrocytoma | Adult Ependymoma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Adult... and other conditions

United States
Bayer

Recruiting

A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems (Quanti CNS)

Contrast Enhancement in Magnetic Resonance Imaging | Central Nervous System Pathology

France, Turkey, Czechia, China, Japan, Korea, Republic of, United Kingdom, Italy, United States, Hungary, Argentina, Bulgaria, Canada, Germany, Sweden
Galmed Research and Development, Ltd.
Virginia Commonwealth University

Not yet recruiting

A Study Evaluating the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Primary Sclerosing Cholangitis

Primary Sclerosing Cholangitis
Pfizer

Completed

The Effect Of Tafamidis Meglumine In Transthyretin Amyloid Polyneuropathy Patients

Transthyretin Amyloid Polyneuropathy (ATTR-PN)

China
Jiangsu Kanion Pharmaceutical Co., Ltd
Beijing Bionovo Medicine Development Co., Ltd.

Completed

A Safety Study of Ginkgolides Meglumine Injection in the Treatment of Ischemic Stroke.

Ischemic Stroke

China
Jiangsu Kanion Pharmaceutical Co., Ltd
Beijing Bionovo Medicine Development Co., Ltd.

Completed

Preliminary Study of Pharmacokinetics of Ginkgolides Meglumine Injection.

Ischemic Stroke

China
Bayer

Completed

Contrast Enhanced MRI of the CNS - Patients With Known Cerebral Neoplastic Lesions.

Neoplastic CNS Lesions

Italy
Pfizer

Completed

The Effect Of Tafamidis For The Transthyretin Amyloid Polyneuropathy Patients With V30M Or Non-V30M Transthyretin

Transthyretin Familial Amyloid Polyneuropathy

Japan
Guerbet

Completed

Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors (REMIND)

Primary Brain Tumor

Colombia, Korea, Republic of, United States, Mexico

Search clinical trials for: Dotarem (gadoterate meglumine)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations